Grit Biotherapeutics
PrivateLast Round
Series B
Sep 8, 2023
Total Funding Raised
$75.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Grit Biotherapeutics is a biopharmaceutical company that develops tumor-infiltrating lymphocyte (TIL) immunotherapies for the treatment of solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Grit Biotherapeutics Comparables
Compare Grit Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioSyngen | 84% | |
| KSQ Therapeutics | 79% | |
| Obsidian Therapeutics | 79% | |
Grit Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 8, 2023 | ||||
| Series A Extension | Jul 15, 2021 | ||||
| Series A | Dec 1, 2020 |
Grit Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yuanhe Capital | Series B |
| China International Capital Corporation | Series B |
| Liando Investment | Series B |
| MPC | Series B, Series A, Series A Extension |
| Sherpa Healthcare Partners | Series B, Series A |
| Decheng Capital | Series B, Series A, Series A Extension |
| Apricot Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 78% MoM.
- Sep 8, 2023
$60M round led by China International Capital Corporation.
Grit Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Grit Biotherapeutics's valuation, stock price, and market status.